Spanish Oncology Genito-urinary Group
Clinical trials sponsored by Spanish Oncology Genito-urinary Group, explained in plain language.
-
Immunotherapy combo may delay progression in advanced bladder cancer
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) could help keep advanced bladder cancer from growing after initial chemotherapy. It involved 25 adults whose cancer had not worsened after first-line chemo. The goal was to see if this m…
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Real-World study checks Tivozanib's performance in kidney cancer
Knowledge-focused CompletedThis completed study looked back at the medical records of 200 patients with advanced clear cell kidney cancer who received Tivozanib as their first treatment. The goal was to see how long patients went without their cancer getting worse and how long they lived overall. The study…
Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC